The Renin-Angiotensin-System (RAS)-Acting Agents Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Renin-Angiotensin-System (RAS)-Acting Agents Market?
The market size of renin-angiotensin-system (RAS)-acting agents has seen robust expansion in recent years. The market, which was worth $5.82 billion in 2024, is projected to grow to $6.17 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.0%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Renin-Angiotensin-System (RAS)-Acting Agents Industry?
The global market size for renin-angiotensin-system (RAS)-acting agents is projected to reach $7.73 billion in 2029, with a compound annual growth rate (CAGR) of 5.8%.
Download Your Free Sample of the 2025 Renin-Angiotensin-System (RAS)-Acting Agents Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Renin-Angiotensin-System (RAS)-Acting Agents Market?
The key drivers in the Renin-Angiotensin-System (RAS)-Acting Agents market are:
• Growing focus on personalized treatment
• Rising demand for fixed-dose combinations
• Increasing investment in cardiovascular research
• Growing healthcare access in emerging markets
Global Market Segmentation: Identifying Major Renin-Angiotensin-System (RAS)-Acting Agents Industry Segments
The renin-angiotensin-system (RAS)-acting agents market covered in this report is segmented –
1) By Drug Class: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Renin Inhibitors, Aldosterone Antagonists, Other Drug Classes
2) By Indication: Hypertension, Heart Failure, Chronic Kidney Disease, Diabetic Nephropathy, Coronary Artery Disease
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics
4) By End-User: Hospitals, Research Institutes, Pharmaceutical Companies, Other End-Users
Pre-order the 2025 Renin-Angiotensin-System (RAS)-Acting Agents Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Renin-Angiotensin-System (RAS)-Acting Agents Market?
The key trends in the Renin-Angiotensin-System (RAS)-Acting Agents market are:
• The growing focus on personalized treatment is an emerging trend.
• There is a rising demand for fixed-dose combinations.
• The market is witnessing a surge in the investment in cardiovascular research.
• The rise of cutting-edge technologies like AI, nanotechnology, blockchain, and digital twin technology promises a transformative future.
Who Are the Top Competitors & Leading Players in the Renin-Angiotensin-System (RAS)-Acting Agents Market?
Major companies in the Renin-Angiotensin-System (RAS)-Acting Agents market are:
• Pfizer Inc.
• Merck And Co. Inc.
• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Novartis AG
• GSK plc
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim GmbH
• Sandoz International GmbH
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Aurobindo Pharma Limited
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Biocon Limited
• Daiichi Sankyo Company Limited
• Glenmark Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
Regional Dominance: Which Area Leads the Global Renin-Angiotensin-System (RAS)-Acting Agents Market?
North America was the largest region in the renin-angiotensin-system (RAS)-acting agents market in 2024
